GoodRx Holdings, Inc. — Director's Dealing 2021

Oct 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-10-01

Reporting Person: Slutsky Andrew (President, Consumer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-01	Class A Common Stock	M	62500	—	Acquired	3135535	Direct
2021-10-01	Class A Common Stock	F	30988	$41.02	Disposed	3104547	Direct
2021-10-01	Class A Common Stock	S	3900	$41.5487	Disposed	3100647	Direct
2021-10-01	Class A Common Stock	S	13669	$42.4465	Disposed	3086978	Direct
2021-10-01	Class A Common Stock	S	12555	$43.6743	Disposed	3074423	Direct
2021-10-01	Class A Common Stock	S	4894	$44.2159	Disposed	3069529	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-01	Restricted Stock Units	$	M	62500	Disposed		Class A Common Stock (62500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	222418	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.08 to $42.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.11 to $43.09, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.11 to $44.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.11 to $44.40, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F7: Shares held by The Arisa Slutsky Spousal Trust.

F8: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date.